Clinical Course and Treatment Outcomes of Sorsby Fundus Dystrophy

American Journal of Ophthalmology

Volumn 146, Issue 2, 2008, Pages

  Sivaprasad, Sobha ^a   Webster, Andrew R ^a   Egan, Catherine A ^a   Bird, Alan C ^a   Tufail, Adnan ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR;

ADULT; ARGON LASER; ARTICLE; BLINDNESS; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE COURSE; GENE MUTATION; HUMAN; LASER COAGULATION; MEDICAL RECORD REVIEW; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DYSTROPHY; RETROSPECTIVE STUDY; SORSBY FUNDUS DYSTROPHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 47549086860     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.03.024     Document Type: Article

References (32)

1. Weber B.H., Vogt G., Pruett R.C., Stohr H., and Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 8 (1994) 352-356
2. Tabata Y., Isashiki Y., Kamimura K., Nakao K., and Ohba N. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features. Hum Genet 103 (1998) 179-182
3. Langton K.P., McKie N., Curtis A., et al. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J Biol Chem 275 (2000) 27027-27031
4. Barbazetto I.A., Hayashi M., Klais C.M., Yannuzzi L.A., and Allikmets R. A novel TIMP3 mutation associated with Sorsby fundus dystrophy. Arch Ophthalmol 123 (2005) 542-543
5. Jacobson S.G., Cideciyan A.V., Bennett J., Kingsley R.M., Sheffield V.C., and Stone E.M. Novel mutation in the TIMP3 gene causes Sorsby fundus dystrophy. Arch Ophthalmol 120 (2002) 376-379
6. Gregory-Evans K. What is Sorsby's fundus dystrophy?. Br J Ophthalmol 84 (2000) 679-680
7. Ashton N., and Sorsby A. Fundus dystrophy with unusual features; a histological study. Br J Ophthalmol 35 (1951) 751-764
8. Yates J.R., and Moore A.T. Genetic susceptibility to age-related macular degeneration. J Med Genet 37 (2000) 83-87
9. Wijesuriya S.D., Evans K., Jay M.R., et al. Sorsby's fundus dystrophy in the British Isles: demonstration of a striking founder effect by microsatellite-generated haplotypes. Genome Res 6 (1996) 92-101
10. Berninger T.A., Polkinghorne P.J., Capon M.R., et al. Color vision defect. A early sign of Sorsby retinal dystrophy?. Ophthalmologe 90 (1993) 515-518
11. Steinmetz R.L., Polkinghorne P.C., Fitzke F.W., Kemp C.M., and Bird A.C. Abnormal dark adaptation and rhodopsin kinetics in Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci 33 (1992) 1633-1636
12. Pauleikhoff D., Chen J.C., Chisholm I.H., and Bird A.C. Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol 109 (1990) 211-217
13. Polkinghorne P.J., Capon M.R., Berninger T., Lyness A.L., Sehmi K., and Bird A.C. Sorsby's fundus dystrophy: a clinical study. Ophthalmology 96 (1989) 1763-1768
14. Capon M.R., Marshall J., Krafft J.I., Alexander R.A., Hiscott P.S., and Bird A.C. Sorsby's fundus dystrophy: a light and electron microscopic study. Ophthalmology 96 (1989) 1769-1777
15. Capon M.R., Polkinghorne P.J., Fitzke F.W., and Bird A.C. Sorsby's pseudoinflammatory macula dystrophy-Sorsby's fundus dystrophies. Eye 2 (1988) 114-122
16. Hoskin A., Sehmi K., and Bird A.C. Sorsby's pseudoinflammatory macular dystrophy. Br J Ophthalmol 65 (1981) 859-865
17. Gregory C.Y., Wijesuriya S., Evans K., Jay M., Bird A.C., and Bhattacharya S.S. Linkage refinement localises Sorsby fundus dystrophy between markers D22S275 and D22S278. J Med Genet 32 (1995) 240-241
18. Chong N.H., Kvanta A., Seregard S., Bird A.C., Luthert P.J., and Steen B. TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy. Am J Ophthalmol 136 (2003) 954-955
19. Felbor U., Doepner D., Schneider U., Zrenner E., and Weber B.H. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. Invest Ophthalmol Vis Sci 38 (1997) 1054-1059
20. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 117 (1999) 1329-1345
21. Ayyagari R., Griesinger I.B., Bingham E., Lark K.K., Moroi S.E., and Sieving P.A. Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene. Arch Ophthalmol 118 (2000) 85-92
22. Hamilton W.K., Ewing C.C., Ives E.J., and Carruthers J.D. Sorsby's fundus dystrophy. Ophthalmology 96 (1989) 1755-1762
23. Soboleva G., Geis B., Schrewe H., and Weber B.H. Sorsby fundus dystrophy mutation TIMP3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis. J Cell Physiol 197 (2003) 149-156
24. Fariss R.N., Apte S.S., Luthert P.J., Bird A.C., and Milam A.H. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol 82 (1998) 1329-1334
25. Qi J.H., Ebrahem Q., and Anand-Apte B. Tissue inhibitor of metalloproteinases-3 and Sorsby fundus dystrophy. Adv Exp Med Biol 533 (2003) 97-105
26. Qi J.H., Ebrahem Q., Moore N., et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9 (2003) 407-415
27. Anand-Apte B., Pepper M.S., Voest E., et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 38 (1997) 817-823
28. Yeow K.M., Kishnani N.S., Hutton M., Hawkes S.P., Murphy G., and Edwards D.R. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix. Matrix Biol 21 (2002) 75-88
29. Holz F.G., Haimovici R., Wagner D.G., and Bird A.C. Recurrent choroidal neovascularization after laser photocoagulation in Sorsby's fundus dystrophy. Retina 14 (1994) 329-334
30. Wong S.C., Fong K.C., Lee N., Gregory-Evans K., and Gregory-Evans C.Y. Successful photodynamic therapy for subretinal neovascularisation due to Sorsby's fundus dystrophy: 1 year follow-up. Br J Ophthalmol 87 (2003) 796-797
31. Peiretti E., Klancnik Jr. J.M., Spaide R.F., and Yannuzzi L. Choroidal neovascularization in Sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide. Retina 25 (2005) 377-379
32. Atan D., Gregory Evans C.Y., Louis D., and Downes S.M. Sorsby fundus dystrophy presenting with choroidal neovascularisation showing good response to steroid treatment. Br J Ophthalmol 88 (2004) 440-441